Large cell neuroendocrine carcinoma of the prostate: a systematic review and pooled analysis

X Tu, T Chang, L Nie, S Qiu, H Xu, Y Huang… - Urologia …, 2019 - karger.com
Background: Large cell neuroendocrine carcinoma (LCNEC) of the prostate is an extremely
rare entity, and the clinicopathological course, potential effective treatment, and prognosis …

A systematic review of primary large cell neuroendocrine carcinoma of the prostate

N Nguyen, RD Franz, O Mohammed, R Huynh… - Frontiers in …, 2024 - frontiersin.org
Background Large cell neuroendocrine carcinoma (LCNEC) is a rare subtype of prostate
cancer. The pathogenesis, clinical manifestation, treatment options, and prognosis are …

De novo large‐cell neuroendocrine carcinoma of the prostate: A case report and literature review

E Fukagawa, T Yuasa, K Inamura, K Hamada… - IJU Case …, 2022 - Wiley Online Library
Introduction Prostatic large‐cell neuroendocrine carcinoma is poorly studied. Although
several case reports are available, information on the clinicopathological characteristics of …

Primary large cell neuroendocrine carcinoma of the prostate in a hormone naive patient: a case report from Taiwan

KY Tzou, WH Cheng, WH Lee… - Journal of Cancer …, 2018 - journals.lww.com
Large cell neuroendocrine carcinoma (LCNEC) of the prostate is extremely rare. Previously
reported cases in the literature were almost exclusively developed in men receiving …

Large cell neuroendocrine carcinoma of prostate: a case report.

Z Shun, W Cheng, Q Su-bo, D Yu… - Journal of Shanghai …, 2020 - search.ebscohost.com
Abstract In August, 2018, a 67-year-old man presenting progressive dysuria and defecation
difficulty for 7 months went to our hospital. tPSA was 24.50 ng/mL. MRI examination …